Color Code
Brown

GAVI Alliance Partner Engagement Framework

971
Image
infectious disease
GAVI Alliance Partner Engagement Framework
Bangladesh
Burkina Faso
Benin
Ethiopia
Haiti
India
Liberia
Mali
Myanmar
Mozambique
Niger
Nigeria
Nepal
Pakistan
Sierra Leone
Senegal
Chad
Zimbabwe
To strengthen vaccine-preventable disease surveillance platforms to maximize their capacity to measure burden of disease and to monitor the impact of vaccines. Activities include improving immunization data quality; evaluating impact and implementation of vaccines (including oral cholera, rubella, and HPV); improving the quality and planning of measles and rubella campaigns; and strengthening surveillance for vaccine preventable diseases (meningitis, diphtheria and pertussis, intussusception).
GAVI
CDC's National Center for Immunization and Respiratory Diseases

Clinical Trials Unit for HIV/AIDS and TB Research

788
Image
Thailand couple
Clinical Trials Unit for HIV/AIDS and TB Research
Bangkok, Thailand
Thailand
To facilitate formation of a Clinical Trials Unit for HIV/AIDS and tuberculosis research to advance therapy and prevention. If the interventions in the clinical trials are determined safe and effective, they will add to the options available to prevent and control these diseases of global significance.
Emory University (National Institutes of Health)
CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

Opt-Out Chlamydia Screening Effectiveness

894
Image
holding hands
Opt-Out Chlamydia Screening Effectiveness
United States of America
To explore the effectiveness of opt-out chlamydia screening via electronic health record prompt and to increase the percentage of women under the age of 25 who are screened for chlamydia at clinical encounters.
Hologic, Inc.
CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention; University of Pittsburgh

Understanding Antibiotic Use Data

870
Image
healthcare setting
Understanding Antibiotic Use Data
United States of America
To gain a comprehensive understanding of antibiotic use in inpatient and outpatient healthcare settings in the United States.
The Pew Charitable Trusts
CDC's National Center for Emerging and Zoonotic Infectious Diseases

Combination HIV Prevention Intervention in Thailand

914
Image
thailand
Combination HIV Prevention Intervention in Thailan
Thailand
To conduct a study to assess the feasibility of a combination HIV preventive intervention with and without daily Truvada PrEP for HIV uninfected young men who have sex with men in Bangkok, Thailand.
Johns Hopkins University (National Institutes of Health/National Institute of Allergy and Infectious Disease)
CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of HIV/AIDS Prevention; Thailand Ministry of Public Health

Healthy Swimming in the United States

252
Image
swimming
Healthy Swimming in the United States
United States of America
To conduct research and raise awareness about preventing recreational water illness associated with the use of treated public water venues such as pools, hot tubs and water parks.
National Swimming Pool Foundation; ESSRX; Lupin Pharmaceuticals; Previous Partners: American Chemistry Council; Chem-Aquascience, Inc.; Lonza Group, Ltd (Arch Chemicals, Inc.); NSPF for CMAHC; Slack, Inc.
CDC's National Center for Emerging and Zoonotic Infectious Diseases

Crimean-Congo Hemorrhagic Fever Study

794
Image
Map
Crimean-Congo Hemorrhagic Fever Study
United States of America
To research the nairovirus, Crimean-Congo hemorrhagic fever, a tick-borne viral disease, especially common in East and West Africa. With mortality rates as high as 80 percent and with no FDA approved vaccines or therapeutics, Crimean-Congo hemorrhagic fever is considered a dangerous pathogen and a serious bioterrorism threat. The project will expand the knowledge of the ovarian tumor protease domain of the nairovirus to inform control measures and vaccine development.
University of Georgia (National Institutes of Health)
CDC's National Center for Emerging and Zoonotic Infectious Diseases

The Sally Schieffelin Potter Endowment for Healthcare-Associated Infections

Safe HeathcareEvery day, about one in every 20 hospitalized patients has an infection caused by receiving medical care. Healthcare-associated infections are caused by a wide variety of bacteria, fungi and viruses, and one in every five healthcare-associated infections are caused by germs that show concerning multidrug resistance. Although many of these infections are preventable, tens of thousands of people die each year as a result, and countless others are left to deal with devastating emotional, financial and medical consequences. These infections cost the U.S. healthcare system up to $45 billion dollars annually.

The Centers for Disease Control and Prevention (CDC) is working toward the elimination of healthcare-associated infections in all medical care settings. CDC is passionate about improving the safety of our nation’s healthcare system, but they cannot do it alone. The CDC Foundation and CDC need the help of businesses globally to bring innovations to patient safety that ensures our healthcare system is fail-proof. There are five key areas where CDC is helping healthcare facilities, doctors and nurses provide safer care for patients, providing better options for healthcare purchasers and saving healthcare dollars. These include:
 

  • Tracking infections in more than 12,000 healthcare facilities to know where the problems are and better target prevention efforts through CDC’s National Healthcare Safety Network;
  • Publishing evidenced-based guidelines that can prevent infections in the first place;
  • Leading novel research to find new strategies to protect patients and help innovators bring new products forward that improve healthcare;
  • Stopping outbreaks and sounding the alarm on emerging threats; and
  • Operating a world-class laboratory that can track drug-resistant threats and evaluate the role of the healthcare environment in infection transmission.

CDCPreventing infections saves lives. There are a variety of innovative business strategies that could help boost CDC’s infection prevention challenges and address emerging threats.

The Sally Schieffelin Potter Endowment for Healthcare-Associated Infections was created to provide financial support to the CDC’s Division of Healthcare Quality Promotion who is working to protect patients wherever they receive their medical care.

In 2013, the Sally Schieffelin Potter Endowment for Healthcare-Associated Infections was used to provide educational materials for healthcare workers and dialysis patients in the nearly 6,000 dialysis facilities in the United States. Each year, about 37,000 bloodstream infections affect kidney dialysis patients with central lines. Following CDC protocols could cut bloodstream infections among dialysis patients in half.

60
Image
HAI
The Sally Schieffelin Potter Endowment
United States of America
To provide support to CDC, working toward the elimination of healthcare-associated infections in all medical care settings.
Multiple individuals and organizations; Previous Partner: The Sally Schieffein Potter Endowment
CDC's National Center for Emerging and Zoonotic Infectious Diseases
Subscribe to Infectious Disease